Shantanu Basu Joins Mintz Levin's Silicon Valley Office
6/12/2008
Firm's Intellectual Property Practice Continues to Expand
Palo Alto, CA – Continuing the expansion of the firm's West Coast Intellectual Property practice, Shantanu Basu, most recently of Morrison & Foerster LLP, has joined Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. in the firm's Palo Alto office.
Dr. Basu represents companies in biotechnology, pharmaceutical, biochip and related industries in patent prosecution, litigation and arbitration matters dealing with both U.S. and international patent laws and procedures. Dr. Basu holds a Ph.D. in molecular biology and brings several years of scientific research experience, in addition to his legal experience, in such areas as virology, AIDS, protein chemistry, gene therapy and molecular biology.
"With complex patent issues in developing and competitive research fields becoming increasingly important, Shantanu's strong R&D background and deep expertise in all types of patent matters will be a most valuable resource as we continue to expand the firm's IP practice and its Silicon Valley office," said Robert P. Taylor, Managing Member of the Palo Alto office.
As a lawyer, Dr. Basu has dealt with an array of issues including patent interference, reexamination and reissue proceedings. He has experience in intellectual property licensing, IP due diligence in financial transactions, validity analysis and strategic counseling.
Dr. Basu holds a Bachelor of Science degree in chemistry and a Master of Science degree in biochemistry from the University of Calcutta, India. He also earned a Master of Science degree and a Ph.D. in molecular biology from Albert Einstein College of Medicine in New York and his J.D. from Fordham University Law School. Prior to obtaining his J.D., Dr. Basu investigated the replication of the HIV and Murine Leukemia viruses as a post-doctoral fellow at the University of California Medical Center in San Francisco. Dr. Basu is admitted to the State courts in California, New York and New Jersey and he is registered to practice before the U.S. District Courts for Northern California and New Jersey as well as the United States Patent and Trademark Office.
Mintz Levin is one of the leading law firms in the intellectual property and life science areas, with more than 90 attorneys, scientists and other professionals focused on the protection, licensing and enforcement of intellectual property rights. The firm's roster includes more than 400 clients in the life sciences and technology industries, including: Biogen-Idec, NuVasive, Inc., StemCells Inc., Merck, 454 Life Sciences, Neuromolecular Pharmaceuticals Inc., Coley Pharmaceutical Group, Inc., Curagen Corporation, OSI Pharmaceuticals and Qiagen, Inc.
Mintz Levin is an AmLaw 100 law firm with offices in the US and the UK. The firm has exceptional depth in a broad range of practice areas, but our clients recognize that what sets us apart from other law firms is our industry focus. By truly understanding business drivers and industry trends, we are able to provide our clients with more than just legal advice; we provide legal solutions to our clients' business issues. Since 1933, our lawyers have represented entrepreneurs, emerging growth companies, Fortune 500 companies, government agencies, not-for-profit organizations and leaders in primary industries that include Life Sciences/Biotechnology; Technology & Communications; Energy & Clean Technology; Financial Services & Insurance; Healthcare; Real Estate, Hospitality & Construction; and Retail & Consumer Products. Our practical knowledge combined with our industry expertise enables us to provide our clients with enterprise legal advice that gives their business a competitive advantage in the marketplace.
